Secure: A Prospective Long-Term Observational Study in Patients with Monoclonal Gammopathy of Undetermined Significance
Karthik Ramasamy, Elizabeth Knight, Earnest Heartin, Victoria Garvey et autres
2 citationsBlood
Magda Al-Obaidi
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
17Publications signalées
2331Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchMultiple Myeloma Research and TreatmentsLong-Term Effects of COVID-19Cancer survivorship and care
Publications récentes
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas et autres
132 citationsThe Lancet
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas et autres
334 citationsThe Lancet
P1587: IS IT SAFE FOR OUR PATIENTS TO COME OUT?
Magda Al-Obaidi, A. Chew, C. Liu
0 citationsHemaSphere
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas et autres
384 citationsThe Lancet
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas et autres
292 citationsThe Lancet
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas et autres
526 citationsThe Lancet
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, Alfie Abbott et autres
565 citationsThe Lancet
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO
Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else et autres
6 citationsFrontiers in Pharmacology
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study
Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else et autres
21 citationsFrontiers in Pharmacology
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study
Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else et autres
27 citationsJournal of Comparative Effectiveness Research
Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3
Laura Tornatore, Daria Capece, Daniel D’Andrea, Federica Begalli et autres
18 citationsToxicology Reports
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.